SEBASTIAN, Florida,
July 26, 2018 /PRNewswire/ --
NXT-ID, Inc. (NASDAQ: NXTD or the "Company") today announced
that Robert A. Curtis, Pharm.D.,
MBA, has joined its Board of Directors, effective July 25, 2018. Dr. Curtis, a 35-year veteran of
the bioscience industry, will add a wealth of health care
experience to the Board of Directors.
"Robert a long history of successfully bringing new heathcare
technologies to market and a deep background within the industry,"
said NXT-ID CEO Gino Pereira. "His
expertise and insights will be particularly valuable to the Board
as we develop and execute strategies to grow our healthcare
offerings and expand the market opportunities for that division of
our company."
Dr. Curtis currently serves as a consultant to emerging
technology companies and serves on the board or as an advisor to a
number of private entrepreneurial companies. He recently served as
the Executive Chairman and Director of the Trudeau Institute in
Saranac Lake, NY, as well as Chief
Executive Officer of the Regional Technology Development
Corporation of Cape Cod, MA, where
he was responsible for identifying and commercializing technology
from the Marine Biological Laboratory and the Woods Hole
Oceanographic Institute.
Dr. Curtis has been a Founder and CEO of several companies,
including HistoRx, Inc., Cape Aquaculture Technologies, Inc., and
Lion Pharmaceuticals/Phoenix Drug Discovery LLC. He assisted in the
founding of Environmental Operating Solutions, Inc, which applied
denitrification technology to wastewater with the company being
sold in 2017. He was Co-founder of and CEO of CombiChem, Inc.,
which was purchased by Dupont Pharmaceuticals and served as
founding President and CEO of MetaMorphix, Inc., a joint venture
between Genetics Institute, Inc. and The Johns
Hopkins School of Medicine.
Prior to these entrepreneurial endeavors, Dr. Curtis held senior
management positions at Pharmacopeia, Inc., Cambridge Neuroscience,
Inc., and Pfizer, Inc. He also served as an Assistant Professor of
Pharmacy Practice at the University of
Illinois Medical Center in Chicago. Dr. Curtis holds a Bachelor of
Science in Pharmacy from Massachusetts College
of Pharmacy, a Pharm.D. from University
of Missouri, and a Master Business Administration from
Columbia University
"I am very pleased to join such as talented Board and look
forward to contributing to the strategic direction of the company,"
said Curtis. "My goal will be working with the other Board members
and management team to leverage NXT-ID's healthcare and other
capabilities to bring value for shareholders."
NXT- ID, Inc.
NXT-ID, Inc. (NASDAQ: NXTD) provides a comprehensive platform of
technology products and services that enable the Internet of Things
(IoT). With extensive experience in access control, biometric and
behavior-metric identity verification, security and privacy,
encryption and data protection, payments, miniaturization and
sensor technologies, NXT-ID develops and markets groundbreaking
solutions for payment and IoT applications. Its industry-leading
technology products and solutions include MobileBio®, a suite of
biometric solutions that secure consumers' mobile platforms, the
Wocket™ , a next-generation smart wallet and the Flye, a
digital credit card developed in collaboration with WorldVentures.
NXT-ID includes three mobile and IoT-related subsidiaries:
LogicMark, LLC, a manufacturer and distributor of non-monitored and
monitored personal emergency response systems ("PERS") sold through
dealers/distributors and the United States Department of Veterans
Affairs; Fit Pay, Inc., a proprietary technology platform that
delivers end-to-end solutions to device manufacturers for
contactless payment capabilities, credential management,
authentication and other secure services within the IoT ecosystem,
and 3D-ID LLC, which is engaged in biometric identification and
authentication. Learn more about NXT-ID at www.nxt-id.com. NXT-ID
Inc. Corporate Contact: info@nxt-id.com. FitPay® and the FitPay®
Payment Platform are trademarks of Fit Pay, Inc.
Forward-Looking Statements for NXT-ID: This press release
contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Forward-looking
statements reflect management's current expectations, as of the
date of this press release, and involve certain risks and
uncertainties. Forward-looking statements include statements herein
with respect to the successful execution of the Company's business
strategy. The Company's actual results could differ materially from
those anticipated in these forward-looking statements as a result
of various factors. Such risks and uncertainties include, among
other things, our ability to establish and maintain the proprietary
nature of our technology through the patent process, as well as our
ability to possibly license from others patents and patent
applications necessary to develop products; the availability of
financing; the Company's ability to implement its long range
business plan for various applications of its technology; the
Company's ability to enter into agreements with any necessary
marketing and/or distribution partners; the impact of competition,
the obtaining and maintenance of any necessary regulatory
clearances applicable to applications of the Company's technology;
and management of growth and other risks and uncertainties that may
be detailed from time to time in the Company's reports filed with
the Securities and Exchange Commission.
Media Contacts:
Chris Orlando
chris@fit-pay.com
+1-760-468-7273
D. Van Zant
press@nxt-id.com
+1-800-665-0411
SOURCE NXT-ID, Inc.